Published: 24 May 2013

New bladder cancer test could save lives

Surrey academics have developed a pioneering urine test that could improve the diagnosis and treatment of bladder cancer.

The test, developed by Dr Richard Morgan and Professor Hardev Pandha looks for traces of the EN-2 protein — which is found in both bladder and prostate cancers — in urine.

The bladder cancer test could reduce the need for invasive treatments such as cystoscopies (where a doctor passes a thin telescope into the bladder via the urethra). This would not only help to improve the quality of life of the 10,000 people diagnosed with the disease annually, but could save the NHS in excess of £100m a year.

Professor Pandha, head of Oncology at the University of Surrey, said: “Bladder cancer is one of the most expensive cancers to manage.   During the course of treatment, patients can endure multiple invasive procedures, used to monitor the success of surgeries and drug therapy programmes.  This simple test challenges the need for such routine and invasive procedures, greatly improving the experience for patients and saving the NHS a considerable amount of money”.

The research, in collaboration with the University of Birmingham, involved analysing urine from a large group of bladder cancer patients and healthy controls and was published in the European Journal of Cancer.

Find out more about our Cancer research and the EN-2 test for prostate cancer, also developed at the University of Surrey.

Share what you've read?